No Data
No Data
List of Conversion Stocks (Part 1) [List of Parabolic Signal Conversion Stocks]
List of buy conversion stocks in the market: Code | Company name | Closing price | SAR Tokyo Stock Exchange Prime Board: 1417 | Miraitowa | 2116 | 2050 1726 | Br.HD | 366 | 360 1766 | Taisei Corporation | 11780 | 11300 1780 | Yamaura | 1337 | 1304 1821 | Mitsumi Construction |
J&J Ends Work on Addex Epilepsy Drug Candidate ADX71149: Report
Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst
Wednesday, Johnson & Johnson (NYSE:JNJ) reported a second-quarter adjusted EPS of $2.82, up 10.2% Y/Y, beating the consensus of $2.70.
These Analysts Revise Their Forecasts On Johnson & Johnson After Q2 Results
Johnson & Johnson (NYSE:JNJ) reported better-than-expected second-quarter earnings on Wednesday.The company posted adjusted EPS of $2.82, up 10.2% year-over-year, beating the consensus of $2.70. The
Med-tech and Healthcare Stocks With Upside During 2Q Earnings - Baird
Comparative Study: Johnson & Johnson And Industry Competitors In Pharmaceuticals Industry
In the dynamic and fiercely competitive business environment, conducting a thorough analysis of companies is crucial for investors and industry enthusiasts. In this article, we will perform an